Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. twitter.com › adrenomedAdrenomed AG (@adrenomed) / Twitter

   twitter.com › adrenomed

   • Im Cache

   16. Nov. 2018 · Adrenomed AG. @adrenomed. An innovative biomarker-guided #precisionmedicine solution for patients in acute care with #sepsis and #septicshock. #enibarcimab. Hennigsdorf, Deutschland adrenomed.com Joined November 2018. 218 Following.

2. twitter.com › adrenomed › statusAdrenomed AG on Twitter: "In #November, meet our CEO and CFO at...

   twitter.com › adrenomed › status

   13. Okt. 2022 · In #November, meet our CEO and CFO at: @LSXLeaders’ Inv€$tival #Showcase November 14, 2022, in-person in #London, UK. 13 Oct 2022 07:41:09

3. adrenomed.comAdrenomed – Adrenomed AG

   adrenomed.com

   • Im Cache

   AdrenoMed AG is a privately-financed, clinical-stage biopharmaceutical company with a clear mission: developing precision medicine to rescue vascular integrity and saving the lives of critically ill patients with limited treatment options. The Company’s lead product candidate is Enibarcimab (INN, former name: Adrecizumab), a clinical-stage ...

4. www.dbi-ag.de › beteiligungen › adrenomedAdrecizumab - Sepsistherapie - Deutsche Biotech Innovativ AG

   www.dbi-ag.de › beteiligungen › adrenomed

   • Im Cache

   Für weitere Informationen besuchen Sie bitte www.adrenomed.com und folgen Sie Adrenomed direkt auf LinkedIn und Twitter . AdreCIZUMAB (INN: Enibarcimab) Antikörper-basierte Therapie zur Verbesserung der Gefäßintegrität

5. de.linkedin.com › company › adrenomed-agAdrenomed AG | LinkedIn

   de.linkedin.com › company › adrenomed-ag

   An innovative biomarker-guided precision medicine solution for patients in acute care with sepsis and septic shock | Adrenomed AG is a German privately financed, clinical-stage biopharmaceutical...

6. adrenomed.com › adrenomed-announces-positive-top-lineAdrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results...

   adrenomed.com › adrenomed-announces-positive-top-line

   • Im Cache

   Hennigsdorf/Berlin (Germany), February 21, 2020 – Adrenomed AG, the vascular integrity company, today reported positive top-line results from its proof-of-concept AdrenOSS-2 Phase II trial. AdrenOSS-2 evaluated the safety, tolerability and efficacy of Adrecizumab, a first-in-class monoclonal antibody targeting the vasoprotective peptide ...

7. adrenomed.com › 20222022 – Adrenomed

   adrenomed.com › 2022

   • Im Cache

   23. Juni 2022 · Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO. Hennigsdorf/Berlin (Germany), 15 March, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Richard Jones as Chief Executive Officer of Adrenomed, effective today. Dr. Jones brings over 25 years of. 15.